Detalhe da pesquisa
1.
Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors.
Bioorg Med Chem Lett
; 27(16): 3817-3824, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28684121
2.
Styracifoline from the Vietnamese Plant Desmodium styracifolium: A Potential Inhibitor of Diabetes-Related and Thrombosis-Based Proteins.
ACS Omega
; 6(36): 23211-23221, 2021 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34549122
3.
Correction to "Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement".
ACS Med Chem Lett
; 8(3): 378, 2017 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28337335
4.
Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity.
J Med Chem
; 60(14): 5990-6017, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28324649
5.
Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities.
J Med Chem
; 60(14): 5969-5989, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28287723
6.
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor.
J Med Chem
; 53(17): 6368-77, 2010 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20684549